Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations
Breast Cancer Research and Treatment · 2024
DOI: 10.1007/s10549-024-07329-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Nora C Elson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgical Oncology, Department of Surgery, TriHealth Cancer Institute, 375 Dixmyth Avenue, Cincinnati, OH, 45220, USA. nora_elson@t…. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Counseling, Genetic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: The NCCN guidelines recommend genetic testing in those patients at increased risk of breast cancer in order to identify candidates for increased frequency of screening or prophylactic mastectomy. However, genetic testing may now identify patients who may benefit from recently developed targeted breast cancer therapy. In order to more widely identify these patients, we implemented genetic counseling for all patients diagnosed with breast cancer. METHODS: In 2021, all patients evaluated within a Midwestern community hospital system diagnosed with breast cancer were offered genetic counseling. This group of patients was compared to a cohort of patients in 2021 who were offered genetic counseling based on NCCN guidelines. With Pearson's chi square, Fisher's Exact test, Mann-Whitney U, and multivariate regression as appropriate, individual demographic data and genetic testing completion between 2019 and 2021 were evaluated. RESULTS: A total of 973 patients were reviewed. 439 were diagnosed with breast cancer in 2019 and 534 in 2021. Demographics and stage at diagnosis (p = 0.194) were similar between years. Completion of genetic testing increased from 204 (46.5%) in 2019 to 338 (63.3%) in 2021 (p < 0.01) with the universal counseling protocol. Specifically, genetic testing completion increased significantly in older patients (p = 0.041) and patients receiving Medicare benefits (p = 0.005). The overall pathogenic variants found increased from 32 to 39 with the most common including BRCA2 (n = 11), CFTR (n = 9), CHEK2 (n = 8), BRCA1 (n = 6). CONCLUSION: Universal genetic counseling was related to a significant increase in genetic testing completion and an increase in pathogenic variants found among breast cancer patients, specifically in subpopulations which may have been previously excluded by traditional NCCN genetic testing screening guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Breast Surgical Oncology, Department of Surgery, TriHealth Cancer Institute, 375 Dixmyth Avenue, Cincinnati, OH, 45220, USA. nora_elson@trihealth.com.
- Department of Genetics, TriHealth Precision Medicine and Genetic Services Institute, Cincinnati, OH, USA.
- Division of Breast Surgical Oncology, Department of Surgery, TriHealth Cancer Institute, 375 Dixmyth Avenue, Cincinnati, OH, 45220, USA.
- TriHealth Hatton Research Institute, Cincinnati, OH, USA.
Zitieren
APA
Elson, N. C., Wernke, K., Yoder, L. M., Fellner, A. N., Raque, K. M., Kuritzky, A. M., & Wexelman, B. A. (2024). Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07329-3
Vancouver
Elson NC, Wernke K, Yoder LM, Fellner AN, Raque KM, Kuritzky AM, et al. Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07329-3
BibTeX
@article{Elson2024,
author = {Elson, Nora C and Wernke, Karen and Yoder, Lauren M and Fellner, Angela N and Raque, Kathleen M and Kuritzky, Anne M and Wexelman, Barbara A},
title = {Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations},
journal = {Breast Cancer Research and Treatment},
year = {2024},
doi = {10.1007/s10549-024-07329-3}
}
EUVIMED